ArticleNeuro-oncology advances

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.

M J Webb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.